Resting-state fMRI sheds light on neural substrates of cognitive decline in Parkinson disease

@article{Shinotoh2014RestingstateFS,
  title={Resting-state fMRI sheds light on neural substrates of cognitive decline in Parkinson disease},
  author={Hitoshi Shinotoh and Alessandro Tessitore},
  journal={Neurology},
  year={2014},
  volume={83},
  pages={2000 - 2001},
  url={https://api.semanticscholar.org/CorpusID:43143547}
}
Resting-state functional MRI is a measure of spontaneous low-frequency fluctuations in the blood oxygen level–dependent (BOLD) signal while the patient lies quietly in the scanner without doing any specific task.
View on Publisher
neurology.org
4 Citations
Methods Citations
1

4 Citations

Differences in dynamic and static functional connectivity between young and elderly healthy adults

Altered dynamic FC demonstrated both qualitatively and quantitatively distinct patterns of transient brain activity and needs to be studied as an imaging biomarker in the aging process.

Imaging Markers of Progression in Parkinson's Disease

Neuroimaging studies, including molecular imaging and MRI are trying to provide insights into the mechanisms underlying Parkinson's disease.

Ambroxol as a disease-modifying treatment to reduce the risk of cognitive impairment in GBA-associated Parkinson’s disease: a multicentre, randomised, double-blind, placebo-controlled, phase II trial. The AMBITIOUS study protocol

This multicentre, double-blind, placebo-controlled, phase II clinical trial randomise patients with GBA-PD in a 1:1 ratio to either oral ABX 1.2 g/day or placebo, and changes in the Montreal Cognitive Assessment score and the frequency of mild cognitive impairment and dementia between baseline and weeks 52 are the primary outcome measures.

Correlations of MC4R and MSH2 expression with obesity in colon cancer patients.

OBJECTIVE To investigate the correlations of MC4R and MSH2 with adult obesity, a total of 46 patients with early-stage colon cancer were treated in our hospital between February 2008 and February…

10 References

Functional connectivity and cognitive decline over 3 years in Parkinson disease

A progressive loss of resting-state functional connectivity over a period of 3 years for multiple brain regions, especially in posterior parts of the brain is demonstrated in patients with PD.

Functional brain networks and cognitive deficits in Parkinson's disease

It is found that patients with MCI had connectivity reductions predominantly affecting long‐range connections as well as increased local interconnectedness manifested as higher measures of clustering, small‐worldness, and modularity.

Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease

The findings revealed a functional disruption of the DMN in cognitively unimpaired patients with PD, in the absence of significant structural differences between patients and controls.

Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging

Recent studies examining spontaneous fluctuations in the blood oxygen level dependent (BOLD) signal of functional magnetic resonance imaging as a potentially important and revealing manifestation of spontaneous neuronal activity are reviewed.

Functional network disruption in the degenerative dementias

Cortico-striatal-thalamic network functional connectivity in hemiparkinsonism

Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study

Investigation dementia in idiopathic PD is heralded by decreased metabolism in the visual association (BA 18) and posterior cingulate cortices, with mild involvement also of the caudate nucleus, according to two-year follow-up data from 5 PDD converters.

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET

Brain cholinergic dysfunction occurs in the cerebral cortex, especially in the medial occipital cortex, and is more widespread and profound in both Parkinson disease with dementia and dementia with Lewy bodies.

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines

These diagnostic criteria will support future research efforts to identify at the earliest stage those PD patients at increased risk of progressive cognitive decline and dementia who may benefit from clinical interventions at a predementia stage.

Clinical validation of movement disorder society–recommended diagnostic criteria for Parkinson's disease with dementia

The MDS‐PD‐D screening checklist is highly accurate for detecting Parkinson's disease dementia if all items are endorsed, however, for cases that do not meet these criteria, full neuropsychological testing is needed to differentiate PD‐D from milder cognitive impairment.